Healthcare Costs: 15% Savings by 2028?

The persistent challenge of rising healthcare costs has made the strategic application of and published savings research not just beneficial, but essential for individuals and organizations alike. Understanding where and how genuine savings can be achieved in health spending requires more than anecdotal evidence. It demands rigorous, transparent investigation. How can we ensure that our efforts to reduce health expenditures are truly effective and not just shifting costs or compromising care quality?

The Alarming Trajectory of Health Expenditure

The United States continues to grapple with healthcare spending that far outpaces other developed nations. In 2024, national health expenditures reached an estimated $4.8 trillion, representing nearly 18% of the Gross Domestic Product, according to data from the Centers for Medicare & Medicaid Services (CMS) (CMS.gov). This isn’t just a macroeconomic issue. It translates directly into higher premiums, larger deductibles, and increasing out-of-pocket costs for everyday Americans. We see this acutely in Georgia, where average family premiums for employer-sponsored health coverage continue their upward climb, often absorbing a significant portion of household income.

The problem isn’t simply spending more. It’s often spending inefficiently. A substantial portion of this expenditure is attributed to administrative complexities, inflated prices for services and pharmaceuticals, and the overuse of low-value care. For instance, a 2023 analysis published in JAMA (JAMA Network) estimated that between 25% and 42% of U.S. healthcare spending is wasteful, totaling hundreds of billions of dollars annually. This waste manifests in various forms: unnecessary tests, ineffective treatments, and administrative overhead that adds little to patient care. Without strong and published savings research, identifying and eliminating these inefficiencies remains a guessing game, rather than a targeted intervention.

What Went Wrong: The Pitfalls of Unsubstantiated Cost-Cutting

In the past, attempts to curb healthcare spending often fell short, sometimes even causing more harm than good. One common, but in the end flawed, approach involved across-the-board budget cuts without a deep understanding of impact. Imagine a large hospital system in Atlanta, like Emory Healthcare, deciding to simply reduce its overall supply budget by 10% without analyzing specific procurement patterns or clinical needs. What happens? Essential, high-value supplies might be cut alongside truly wasteful expenditures, potentially compromising patient outcomes or forcing staff to find more expensive, ad-hoc solutions. This is not a hypothetical. We’ve seen such scenarios play out repeatedly.

Another failed strategy involved relying solely on vendor promises of “cost-saving” technologies or services without independent verification. Many health systems, eager for quick wins, have adopted new platforms or programs based on slick presentations rather than peer-reviewed evidence. These solutions frequently fail to deliver the promised savings, either because their implementation is more complex than anticipated, or because the underlying assumptions about their effectiveness were never rigorously tested. A particularly egregious example involves certain diagnostic imaging centers that promised significant savings through proprietary algorithms, only for later studies to show minimal impact on overall costs, and in some cases, an increase due to subsequent, unnecessary follow-up procedures. This highlights a fundamental truth: without an evidence base, cost-saving initiatives are often just speculative ventures.

The Solution: Embracing Rigorous and Published Savings Research

The path forward demands a commitment to methodical, transparent, and evidence-based approaches to healthcare cost management. This is where and published savings research becomes indispensable. It provides the empirical foundation necessary to differentiate between genuine efficiencies and mere cost-shifting, between effective interventions and those that offer little value. My own experience working with healthcare organizations confirms that the most successful initiatives are those rooted in strong data.

Step 1: Prioritizing Comparative Effectiveness Research (CER)

One of the most powerful tools in our arsenal is Comparative Effectiveness Research (CER). This research directly compares existing healthcare interventions (e.g., medications, medical devices, surgeries, or other treatments) to determine which ones work best for which patients, and under what circumstances. The Agency for Healthcare Research and Quality (AHRQ) (AHRQ.gov) has been a leading proponent and funder of CER, recognizing its potential to guide clinical decisions and resource allocation. For example, CER might compare two different classes of drugs for managing type 2 diabetes, not just on their clinical efficacy, but also on their long-term cost-effectiveness, including potential side effects and subsequent care needs. This isn’t about denying care. It’s about optimizing it.

Consider the field of new oncology treatments. Pharmaceutical companies frequently introduce novel therapies with high price tags, often in the hundreds of thousands of dollars per patient per year. Without rigorous CER, payers and providers are left to make decisions based largely on marketing claims. However, when independent research demonstrates that a less expensive, established treatment offers comparable or even superior outcomes for a specific patient population, the implications for savings are enormous. This allows health systems to negotiate more effectively and guide clinicians toward options that deliver maximum patient benefit for the resources expended. It helps organizations like the Georgia Department of Community Health to make informed decisions for state-sponsored health plans.

Step 2: Using Health Technology Assessment (HTA)

Closely related to CER is Health Technology Assessment (HTA). HTA systematically evaluates the properties and effects of health technologies, including medical devices, pharmaceuticals, and procedures, taking into account their medical, social, ethical, and economic implications. Organizations like the National Institute for Health and Care Excellence (NICE) in the UK (nice.org.uk) have been pioneers in this field, using HTA to determine which treatments and technologies should be funded by their national health service. While the U.S. system is different, the principles of HTA are deeply relevant.

For example, a new robotic surgical system might be marketed as improving patient outcomes and reducing recovery times. An HTA would not only scrutinize the clinical evidence for these claims but also analyze the acquisition cost of the robot, the training required for staff, the maintenance expenses, and the potential impact on surgical volume and reimbursement rates. Sometimes, the “innovative” solution turns out to be significantly more expensive with only marginal, if any, clinical improvement over existing methods. This kind of research prevents health systems from investing millions in technologies that fail to deliver a meaningful return on investment, either clinically or financially. It’s about being discerning, not dismissive, of innovation.

Step 3: Implementing Value-Based Care Models Supported by Research

Shifting from a fee-for-service model to value-based care (VBC) is another critical component, and its success hinges entirely on strong savings research. VBC models incentivize providers to deliver high-quality, cost-effective care by tying reimbursement to patient outcomes and overall cost reduction, rather than the volume of services provided. This requires sophisticated data analytics and a clear understanding of which interventions genuinely improve health while controlling costs.

For instance, research into population health management programs has shown that proactive care for chronic conditions, such as diabetes or heart disease, can significantly reduce emergency room visits and hospitalizations. A study published in Health Affairs (HealthAffairs.org) in 2024 demonstrated that bundled payment models for orthopedic procedures, when designed using evidence-based guidelines, led to a 7% reduction in episode-of-care costs without compromising patient satisfaction or readmission rates. These models don’t just happen. They are built on years of and published savings research that identifies effective care pathways and appropriate cost benchmarks. The Georgia Hospital Association has been actively exploring these models with its member hospitals.

Step 4: Enhancing Price Transparency and Consumer Engagement

Finally, helping consumers with transparent pricing information, backed by research, can drive significant savings. Federal regulations now mandate that hospitals and insurers disclose negotiated prices for a wide range of services. While compliance has been a challenge, the intent is clear: to enable consumers to shop for healthcare services like they would for any other major purchase. Research published by the Healthcare Financial Management Association (HFMA) (HFMA.org) indicates that when consumers actively compare prices for “shoppable” services (e.g., imaging, lab tests, elective procedures), they can save hundreds, sometimes thousands, of dollars. This isn’t just theory. We’re seeing it in practice. Patients in metro Atlanta, for example, can use online tools to compare costs for an MRI at Northside Hospital versus Piedmont Atlanta Hospital, often finding significant variations for the exact same service. This requires sustained effort in data collection and dissemination, ensuring that the information is accessible and understandable to the average person.

Measurable Results: The Impact of Evidence-Based Savings

When organizations commit to incorporating and published savings research into their operational strategies, the results are tangible and impactful. We’re not talking about hypothetical future gains. We’re seeing real-world shifts.

• Reduced Unnecessary Spending: Health systems that systematically review and update their clinical guidelines based on CER findings report a measurable decrease in the utilization of low-value services. One large integrated health system in the Southeast, for example, documented a 10% reduction in unnecessary diagnostic imaging for low back pain over a two-year period (2023-2025) after implementing new evidence-based protocols, translating to millions in annual savings. This was not a random cut. It was a targeted reduction based on clinical evidence.
• Improved Patient Outcomes: Counterintuitively perhaps, focusing on cost-effectiveness often leads to better patient care. By eliminating ineffective treatments and prioritizing those with proven benefits, patients receive more appropriate and timely care. This results in fewer complications, shorter hospital stays, and overall better health status. For instance, strong research on early intervention programs for chronic kidney disease has shown not only a slowing of disease progression but also a significant reduction in the lifetime costs associated with dialysis and transplantation.
• Enhanced Resource Allocation: With a clearer understanding of where healthcare dollars are most effectively spent, providers and payers can allocate resources more strategically. This means investing more in preventive care, primary care, and evidence-based population health initiatives, which often yield a higher return on investment than reactive, acute care. The shift toward identifying and supporting community health workers in underserved areas, for instance, is directly informed by research demonstrating their impact on reducing emergency room visits and improving chronic disease management in those populations.
• Increased Sustainability: For health systems and payers, the long-term adoption of research-backed savings strategies leads to greater financial stability. This sustainability allows for continued investment in innovation, workforce development, and infrastructure, in the end benefiting the entire community. It ensures that essential services remain accessible and that the healthcare system can adapt to future challenges.

The imperative for rigorous and published savings research in health has never been more pressing. As healthcare costs continue to escalate, relying on unsubstantiated claims or arbitrary cuts is a recipe for failure, potentially compromising both financial stability and patient well-being. By embracing comparative effectiveness research, health technology assessments, value-based care models, and price transparency, all grounded in empirical evidence, we can move towards a more efficient, equitable, and sustainable healthcare system. The future of healthcare affordability and quality hinges on our collective commitment to this evidence-based approach, ensuring every dollar spent yields maximum health benefit.